Be The Match BioTherapies expands cord blood unit offerings

Be The Match BioTherapies now offers cryopreserved cord blood units (CBU) as allogeneic cell therapy starting material.

Potential applications of the CBUs include non-clinical, clinical and commercial use.

The company’s registry has more than 266,000 fully-characterized CBUs from domestic cord blood banks.

Be The Patch offers comprehensive characterization information about CBUs to identify therapy-matched units.

Donna Regan, senior director, customer Ready Products at NMDP/Be The Match, said in a news release that the company ensures that the CBUs conform to specific temperature and time guidelines.

The company touts its ability to serve as a single point of contact for CBUs, eliminating the need to qualify and contract with multiple cord blood banks across the country.

Be The Match BioTherapies’ registry includes more than 9 million potential blood stem cell donors in the U.S. Additionally, the company has access to as many as 39 million potential donors internationally.

Be the Match BioTherapies also provides follow-up tracking for the first two FDA-approved CAR-T therapies.

The company has forged or expanded several alliances in recent years.

In October 2020, the company expanded a collaboration with Gamida Cell (Nasdaq:GMDA) related to omidubicel, Gamida Cell’s cell therapy in Phase 3 clinical trials.

It announced a partnership with Lonza in late 2020 related to the cell and gene therapy supply chain.

In late 2021, Be The Match BioTherapies entered into a partnership with Vineti, which has developed a platform for cell and gene therapy supply chains.

Early this year, Be The Match BioTherapies announced that it had extended a collaboration with Atara Biotherapeutics (Nasdaq:ATRA) to offer healthy donor cells for Atara’s off-the-shelf T-cell immunotherapy platform for cancer and autoimmune disease patients.

The company also has a research partnership with the Center for International Blood and Marrow Transplant Research (CIBMTR).

Be The Match BioTherapies is a division of the National Marrow Donor Program/Be The Match.